World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
UK
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
108
Citations
51579
World Ranking
1037
National Ranking
55

Medicine

D-Index
105
Citations
49792
World Ranking
6697
National Ranking
649

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in United Kingdom Leader Award
  • 2025 - Research.com Biology and Biochemistry in United Kingdom Leader Award

Overview

Christopher J. Lord is affiliated with the Institute of Cancer Research in the United Kingdom. Their research primarily falls within the broader field of Social Sciences, with a concentration on Political Science and International Relations as well as Sociology and Political Science.

Their scholarly work addresses various aspects of European governance, law, and policy. The main topics of study in their research include:

  • European Union Policy and Governance
  • Social Policy and Reform Studies
  • European and International Law Studies
  • Political Systems and Governance
  • Political Philosophy and Ethics
  • Philosophy, Sociology, Political Theory

Recent papers authored by Christopher J. Lord cover various dimensions of political and legal studies. These publications include:

  • Autonomy or Domination? Two Faces of Differentiated Integration, 2021, Swiss Political Science Review
  • Democracy at the EU level: Folly or necessity? More work for a directly elected European Parliament, 2020, European Law Journal
  • The European Parliament and Brexit, 2021, SSRN Electronic Journal
  • David Levi-Faur and Frans van Waarden (eds), Democratic Empowerment in the European Union, 2021, European Review of International Studies
  • The institutional consequences of emergency politics at the national and European levels, 2023, Zenodo (CERN European Organization for Nuclear Research)

Christopher J. Lord has collaborated with several frequent co-authors, highlighting interconnected research efforts in their fields. Notable co-authors include:

  • John Erik Fossum
  • Marion Deville
  • Kalypso Nicolaïdis
  • Albert Weale
  • Arto Väisänen

The venues publishing their work represent an array of respected journals and platforms in political and legal studies, such as:

  • Swiss Political Science Review
  • European Law Journal
  • SSRN Electronic Journal
  • European Review of International Studies
  • Zenodo (CERN European Organization for Nuclear Research)

Christopher J. Lord's research intersects significant dimensions of social and political science, particularly focusing on the governance mechanisms and legal frameworks within the European Union context. Their contribution spans theoretical and applied perspectives on institutional dynamics, democracy, and policy reforms in Europe.

Best Publications

  • Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

    Hannah Farmer;Nuala McCabe;Christopher J. Lord;Andrew N. J. Tutt;Andrew N. J. Tutt

  • DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

    Joaquin Mateo;Suzanne Carreira;Shahneen Sandhu;Susana Miranda

  • PARP inhibitors: Synthetic lethality in the clinic

    Christopher J. Lord;Alan Ashworth

  • The DNA damage response and cancer therapy

    Christopher J. Lord;Alan Ashworth

  • Rethinking ovarian cancer: recommendations for improving outcomes

    Sebastian Vaughan;Jermaine I. Coward;Robert C. Bast;Andy Berchuck

  • Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.

    Nuala McCabe;Nicholas C. Turner;Christopher J. Lord;Katarzyna Kluzek

  • Resistance to therapy caused by intragenic deletion in BRCA2

    Stacey L. Edwards;Rachel Brough;Christopher J. Lord;Rachael Natrajan

  • Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

    Ana M. Mendes-Pereira;Sarah A. Martin;Rachel Brough;Afshan McCarthy

  • Germline mutations in RAD51D confer susceptibility to ovarian cancer

    Chey Loveday;Clare Turnbull;Emma Ramsay;Deborah Hughes

  • The Shieldin complex mediates 53BP1-dependent DNA repair

    Sylvie M. Noordermeer;Sylvie M. Noordermeer;Salomé Adam;Dheva Setiaputra;Marco Barazas

  • A decade of clinical development of PARP inhibitors in perspective.

    J. Mateo;C.J. Lord;V. Serra;A. Tutt;A. Tutt

  • BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency

    Yuqiao Shen;Farah L. Rehman;Ying Feng;Julia Boshuizen

  • Genetic interactions in cancer progression and treatment.

    Alan Ashworth;Christopher J. Lord;Jorge S. Reis-Filho

  • Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors

    Christopher J Lord;Andrew N J Tutt;Alan Ashworth

  • Mechanisms of resistance to therapies targeting BRCA-mutant cancers

    Christopher J Lord;Alan Ashworth

  • Synthetic lethal therapies for cancer: what's next after PARP inhibitors?

    Alan Ashworth;Christopher J. Lord

  • Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.

    Jane Goodall;Joaquin Mateo;Joaquin Mateo;Wei Yuan;Helen Mossop

  • A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

    Nicholas C Turner;Christopher J Lord;Elizabeth Iorns;Rachel Brough

  • PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

    Konstantin J. Dedes;Daniel Wetterskog;Ana M. Mendes-Pereira;Rachael Natrajan

  • Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.

    Louise J Barber;Shahneen Sandhu;Lina Chen;James Campbell

Frequent Co-Authors

Alan Ashworth
Alan Ashworth University of California, San Francisco
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Rachael Natrajan
Rachael Natrajan Institute of Cancer Research
Andrew Tutt
Andrew Tutt Institute of Cancer Research
Alan Mackay
Alan Mackay Institute of Cancer Research
Nicholas C. Turner
Nicholas C. Turner Royal Marsden NHS Foundation Trust
Chris Jones
Chris Jones Institute of Cancer Research
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust
John A. Todd
John A. Todd University of Oxford
Marketa Zvelebil
Marketa Zvelebil University of Basel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Christopher J. Lord

Trending Scientists